Integrating therapies for surgical adult soft tissue sarcoma patients

Daniel P. Milgrom, Amikar Sehdev, Joshua K. Kays, Leonidas Koniaris

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Sarcomas are an uncommon group of over 50 different individual histological malignancies arising from mesenchymal (non-epithelial or connective) tissues. Overall, they constitute 1% of human malignancies with an annual incidence rate of fewer than 5 patients per million. Sarcoma may arise from any mesenchymal cell lineages including fat, muscle, or other connective tissues. Due to the rarity of these groups of malignancies, many subtypes were, and still today, are managed as a single entity. This review focused on soft tissue sarcomas with an emphasis on how to integrate therapies for patients with this rare disorder. The role for surgical resection in cure and palliation as well as the relative benefits of adjuvant therapies such as chemotherapy and radiation therapy are discussed.

Original languageEnglish (US)
Article number88
JournalTranslational Gastroenterology and Hepatology
Volume3
Issue numberNovember
DOIs
StatePublished - Nov 1 2018

Fingerprint

Sarcoma
Connective Tissue
Neoplasms
Cell Lineage
Radiotherapy
Therapeutics
Fats
Drug Therapy
Muscles
Incidence

Keywords

  • Disparities
  • Gastrointestinal stromal tumors (GIST)
  • Liposarcoma
  • Malignant fibrohistiosarcoma (MFH)
  • Sarcoma
  • Stromal

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Integrating therapies for surgical adult soft tissue sarcoma patients. / Milgrom, Daniel P.; Sehdev, Amikar; Kays, Joshua K.; Koniaris, Leonidas.

In: Translational Gastroenterology and Hepatology, Vol. 3, No. November, 88, 01.11.2018.

Research output: Contribution to journalReview article

@article{36a1335c1dcd429189bc7d8af7f9bf6e,
title = "Integrating therapies for surgical adult soft tissue sarcoma patients",
abstract = "Sarcomas are an uncommon group of over 50 different individual histological malignancies arising from mesenchymal (non-epithelial or connective) tissues. Overall, they constitute 1{\%} of human malignancies with an annual incidence rate of fewer than 5 patients per million. Sarcoma may arise from any mesenchymal cell lineages including fat, muscle, or other connective tissues. Due to the rarity of these groups of malignancies, many subtypes were, and still today, are managed as a single entity. This review focused on soft tissue sarcomas with an emphasis on how to integrate therapies for patients with this rare disorder. The role for surgical resection in cure and palliation as well as the relative benefits of adjuvant therapies such as chemotherapy and radiation therapy are discussed.",
keywords = "Disparities, Gastrointestinal stromal tumors (GIST), Liposarcoma, Malignant fibrohistiosarcoma (MFH), Sarcoma, Stromal",
author = "Milgrom, {Daniel P.} and Amikar Sehdev and Kays, {Joshua K.} and Leonidas Koniaris",
year = "2018",
month = "11",
day = "1",
doi = "10.21037/tgh.2018.10.12",
language = "English (US)",
volume = "3",
journal = "Translational Gastroenterology and Hepatology",
issn = "2224-476X",
publisher = "AME Publishing Company",
number = "November",

}

TY - JOUR

T1 - Integrating therapies for surgical adult soft tissue sarcoma patients

AU - Milgrom, Daniel P.

AU - Sehdev, Amikar

AU - Kays, Joshua K.

AU - Koniaris, Leonidas

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Sarcomas are an uncommon group of over 50 different individual histological malignancies arising from mesenchymal (non-epithelial or connective) tissues. Overall, they constitute 1% of human malignancies with an annual incidence rate of fewer than 5 patients per million. Sarcoma may arise from any mesenchymal cell lineages including fat, muscle, or other connective tissues. Due to the rarity of these groups of malignancies, many subtypes were, and still today, are managed as a single entity. This review focused on soft tissue sarcomas with an emphasis on how to integrate therapies for patients with this rare disorder. The role for surgical resection in cure and palliation as well as the relative benefits of adjuvant therapies such as chemotherapy and radiation therapy are discussed.

AB - Sarcomas are an uncommon group of over 50 different individual histological malignancies arising from mesenchymal (non-epithelial or connective) tissues. Overall, they constitute 1% of human malignancies with an annual incidence rate of fewer than 5 patients per million. Sarcoma may arise from any mesenchymal cell lineages including fat, muscle, or other connective tissues. Due to the rarity of these groups of malignancies, many subtypes were, and still today, are managed as a single entity. This review focused on soft tissue sarcomas with an emphasis on how to integrate therapies for patients with this rare disorder. The role for surgical resection in cure and palliation as well as the relative benefits of adjuvant therapies such as chemotherapy and radiation therapy are discussed.

KW - Disparities

KW - Gastrointestinal stromal tumors (GIST)

KW - Liposarcoma

KW - Malignant fibrohistiosarcoma (MFH)

KW - Sarcoma

KW - Stromal

UR - http://www.scopus.com/inward/record.url?scp=85057616343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057616343&partnerID=8YFLogxK

U2 - 10.21037/tgh.2018.10.12

DO - 10.21037/tgh.2018.10.12

M3 - Review article

VL - 3

JO - Translational Gastroenterology and Hepatology

JF - Translational Gastroenterology and Hepatology

SN - 2224-476X

IS - November

M1 - 88

ER -